enVVeno Medical Corporation (NVNO)
NVNO Stock Price Chart
Explore enVVeno Medical Corporation interactive price chart. Choose custom timeframes to analyze NVNO price movements and trends.
NVNO Company Profile
Discover essential business fundamentals and corporate details for enVVeno Medical Corporation (NVNO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
31 May 2018
Employees
37.00
Website
https://www.envveno.comCEO
Robert A. Berman
Description
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
NVNO Financial Timeline
Browse a chronological timeline of enVVeno Medical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is -$4.69, while revenue estimate is $1.00m.
Earnings released on 7 May 2026
EPS came in at -$5.89 surpassing the estimated -$8.40 by +29.88%.
Earnings released on 26 Mar 2026
EPS came in at -$10.53 falling short of the estimated -$9.80 by -7.45%.
Stock split effective on 20 Jan 2026
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Oct 2025
EPS came in at -$8.07 surpassing the estimated -$10.50 by +23.14%.
Earnings released on 31 Jul 2025
EPS came in at -$0.33 falling short of the estimated -$0.28 by -17.86%.
Earnings released on 30 Apr 2025
EPS came in at -$0.22 surpassing the estimated -$0.34 by +35.29%.
Earnings released on 27 Feb 2025
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%.
Earnings released on 30 Oct 2024
EPS came in at -$0.35 falling short of the estimated -$0.33 by -6.06%.
Earnings released on 31 Jul 2024
EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%.
Earnings released on 8 May 2024
EPS came in at -$0.31 surpassing the estimated -$0.40 by +22.50%.
Earnings released on 29 Feb 2024
EPS came in at -$0.32 surpassing the estimated -$0.46 by +30.43%.
Earnings released on 26 Oct 2023
EPS came in at -$0.45 surpassing the estimated -$0.48 by +6.25%.
Earnings released on 31 Jul 2023
EPS came in at -$0.58 falling short of the estimated -$0.49 by -18.37%.
Earnings released on 1 May 2023
EPS came in at -$0.57 falling short of the estimated -$0.48 by -18.75%.
Earnings released on 2 Mar 2023
EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%.
Earnings released on 27 Oct 2022
EPS came in at -$0.54 falling short of the estimated -$0.52 by -3.85%.
Earnings released on 3 Aug 2022
EPS came in at -$0.63 falling short of the estimated -$0.33 by -90.91%.
Earnings released on 29 Apr 2022
EPS came in at -$0.47 falling short of the estimated -$0.29 by -62.07%.
Earnings released on 28 Mar 2022
EPS came in at -$0.94 falling short of the estimated -$0.33 by -184.85%.
Earnings released on 12 Nov 2021
EPS came in at -$0.26 surpassing the estimated -$0.34 by +23.53%.
Earnings released on 11 Aug 2021
EPS came in at -$0.28 surpassing the estimated -$0.34 by +17.65%.
NVNO Stock Performance
Access detailed NVNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
